Malaria vaccine candidate RTS,S reduces the risk of malaria by half in African children, study finds
Tuesday, October 18, 2011 - 13:30
in Health & Medicine
First results from a large-scale Phase III trial of RTS,S* show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile.